Get the Stockscreener App
65.70
7.86%
4.79
After Hours:
62.29
-3.41
-5.19%
Novozymes AS ADR Stock (NVZMY) Forecast
The Novozymes AS ADR (NVZMY) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $15.21, representing a -76.85% decrease from the current price of $65.70. The highest analyst price target is $15.80, and the lowest is $14.62.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NVZMY Price Target
Average 18.57
(-71.74% Downside)
Long-term NVZMY price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Novozymes AS ADR financial reports and earnings history, Novozymes AS ADR (NVZMY) stock could reach $124.21 by 2030, $382.64 by 2040 and $539.41 by 2050. See the projected annual prices until 2050 of the Novozymes AS ADR stock below:
- Novozymes AS ADR (NVZMY) is expected to reach an average price of $247.84 in 2035, with a high prediction of $250.11 and a low estimate of $248.15. This indicates an $277.23% rise from the last recorded price of $65.70.
- Novozymes AS ADR (NVZMY) stock is projected to chart a bullish course in 2040, with an average price target of $375.77, representing an $471.95% surge from its current level. The forecast ranges from a conservative $376.09 to a sky-high $382.64.
- Our analysts predict Novozymes AS ADR (NVZMY) to jump 674.49% by 2045, soaring from $412.12 to an average price of $508.84, potentially reaching $516.81. While $412.12 is the low estimate, the potential upside is significant.
- Novozymes AS ADR (NVZMY) stock is expected to climb by 2050, reaching an average of $529.88, a $706.51% jump from its current level. However, a wide range of estimates exists, with high and low targets of $539.41 and $520.34, respectively, highlighting the market's uncertainty.
Novozymes AS ADR Stock (NVZMY) Year by Year Forecast
Novozymes AS ADR Stock (NVZMY) Price Forecast for 2025
Novozymes AS ADR Stock (NVZMY) is expected to reach an average price of $13.49 in 2025, with a high prediction of $26.56 and a low estimate of $0.4174. This indicates an -79.47% fall from the last recorded price of $65.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2025 | $16.73 | $14.62 | $15.80 | -74.53% |
| July, 2025 | $9.3452 | $11.11 | $13.04 | -85.78% |
| August, 2025 | $2.337 | $3.657 | $3.4365 | -96.44% |
| September, 2025 | $23.28 | $0.4174 | $18.98 | -64.57% |
| October, 2025 | $22.53 | $20.03 | $21.32 | -65.71% |
| November, 2025 | $28.33 | $23.95 | $24.24 | -56.88% |
| December, 2025 | $21.69 | $23.82 | $26.56 | -66.99% |
Novozymes AS ADR Stock (NVZMY) Price Forecast for 2026
The predicted value for Novozymes AS ADR (NVZMY) in 2026 is set at an average of $28.42. Estimates vary from a peak of $48.07 to a trough of $8.7659, indicating an -56.75% surge from the present price of $65.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $15.50 | $15.76 | $20.61 | -76.41% |
| February, 2026 | $8.0659 | $8.7659 | $13.55 | -87.72% |
| March, 2026 | $31.10 | $16.87 | $30.83 | -52.67% |
| April, 2026 | $32.87 | $33.72 | $33.24 | -49.96% |
| May, 2026 | $37.49 | $36.86 | $36.72 | -42.93% |
| June, 2026 | $30.12 | $32.07 | $37.31 | -54.15% |
| July, 2026 | $22.38 | $23.70 | $23.88 | -65.94% |
| August, 2026 | $46.80 | $18.60 | $42.69 | -28.76% |
| September, 2026 | $45.32 | $43.18 | $44.11 | -31.03% |
| October, 2026 | $50.39 | $46.56 | $46.30 | -23.31% |
| November, 2026 | $42.83 | $44.96 | $48.07 | -34.81% |
| December, 2026 | $35.91 | $36.17 | $41.57 | -45.34% |
Novozymes AS ADR Stock (NVZMY) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Novozymes AS ADR (NVZMY) is $49.01, with a high forecast of $69.57 and a low forecast of $28.44. This indicates an -25.41% decrease from the last price of $65.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $27.74 | $28.44 | $33.77 | -57.77% |
| February, 2027 | $53.72 | $36.36 | $54.54 | -18.24% |
| March, 2027 | $55.30 | $54.76 | $55.84 | -15.83% |
| April, 2027 | $59.18 | $59.10 | $58.59 | -9.92% |
| May, 2027 | $50.90 | $53.03 | $58.82 | -22.53% |
| June, 2027 | $42.42 | $43.74 | $44.47 | -35.43% |
| July, 2027 | $66.47 | $38.28 | $66.39 | +1.17% |
| August, 2027 | $68.11 | $66.34 | $66.90 | +3.66% |
| September, 2027 | $72.45 | $69.17 | $68.36 | +10.27% |
| October, 2027 | $67.65 | $68.60 | $69.57 | +2.96% |
| November, 2027 | $56.32 | $56.58 | $62.53 | -14.28% |
| December, 2027 | $47.42 | $48.12 | $54.00 | -27.83% |
Novozymes AS ADR Stock (NVZMY) Price Forecast for 2028
In 2028, Novozymes AS ADR (NVZMY) is projected to reach an average price of $78.90, with a high projection of $101.95 and a low estimate of $55.85. This indicates an +20.10% rise from the last price of $65.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $77.41 | $55.85 | $78.25 | +17.82% |
| February, 2028 | $77.72 | $79.67 | $78.45 | +18.30% |
| March, 2028 | $80.88 | $80.97 | $80.46 | +23.10% |
| April, 2028 | $73.35 | $73.99 | $80.33 | +11.64% |
| May, 2028 | $62.46 | $63.78 | $70.51 | -4.93% |
| June, 2028 | $90.18 | $57.96 | $90.10 | +37.25% |
| July, 2028 | $90.90 | $89.50 | $89.69 | +38.35% |
| August, 2028 | $94.50 | $91.66 | $90.41 | +43.84% |
| September, 2028 | $88.97 | $89.92 | $91.40 | +35.42% |
| October, 2028 | $76.73 | $76.99 | $83.49 | +16.78% |
| November, 2028 | $67.09 | $67.79 | $74.23 | +2.12% |
| December, 2028 | $100.40 | $75.35 | $101.95 | +52.81% |
Novozymes AS ADR Stock (NVZMY) Price Forecast for 2029
The 2029 price forecast for Novozymes AS ADR Stock (NVZMY) is $101.64 on average, with a high prediction of $125.66 and a low estimate of $77.63. This represents an +54.71% increase from the previous price of $65.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $100.15 | $101.08 | $101.08 | +52.43% |
| February, 2029 | $102.57 | $102.66 | $102.34 | +56.11% |
| March, 2029 | $94.31 | $94.95 | $101.83 | +43.54% |
| April, 2029 | $82.51 | $83.83 | $91.29 | +25.58% |
| May, 2029 | $113.88 | $77.63 | $113.80 | +73.34% |
| June, 2029 | $113.90 | $112.65 | $112.27 | +73.36% |
| July, 2029 | $116.56 | $114.01 | $112.48 | +77.41% |
| August, 2029 | $110.29 | $111.24 | $113.28 | +67.88% |
| September, 2029 | $96.10 | $103.49 | $104.45 | +46.27% |
| October, 2029 | $86.77 | $87.47 | $94.93 | +32.07% |
| November, 2029 | $123.74 | $94.84 | $125.66 | +88.34% |
| December, 2029 | $122.57 | $124.23 | $123.87 | +86.56% |
Novozymes AS ADR Stock (NVZMY) Price Forecast for 2030
Novozymes AS ADR Stock (NVZMY) is expected to reach an average price of $123.34 in 2030, with a high forecast of $149.36 and a low forecast of $97.31. This signifies an +87.73% surge from the last price of $65.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $124.26 | $124.35 | $124.21 | +89.13% |
| February, 2030 | $115.27 | $115.91 | $123.34 | +75.44% |
| March, 2030 | $104.67 | $107.42 | $112.06 | +59.32% |
| April, 2030 | $137.59 | $97.31 | $137.51 | +109.42% |
| May, 2030 | $136.87 | $135.81 | $135.65 | +108.33% |
| June, 2030 | $136.63 | $136.51 | $135.27 | +107.97% |
| July, 2030 | $131.62 | $132.57 | $135.15 | +100.33% |
| August, 2030 | $116.69 | $124.08 | $125.41 | +77.61% |
| September, 2030 | $106.45 | $107.15 | $115.33 | +62.02% |
| October, 2030 | $147.08 | $114.33 | $149.36 | +123.86% |
| November, 2030 | $147.69 | $147.39 | $146.73 | +124.80% |
| December, 2030 | $145.95 | $146.04 | $146.09 | +122.14% |
0.36%
1.78%
Cap:
|
Volume (24h):